Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730806 | SCV000858569 | benign | not specified | 2017-12-26 | criteria provided, single submitter | clinical testing | |
Al Jalila Children’s Genomics Center, |
RCV000730806 | SCV001984257 | likely benign | not specified | 2020-01-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002533071 | SCV003325712 | uncertain significance | Townes syndrome | 2023-07-28 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with SALL1-related conditions. This variant, c.466_477dup, results in the insertion of 4 amino acid(s) of the SALL1 protein (p.Ser156_Ser159dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 591869). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gharavi Laboratory, |
RCV000723051 | SCV000854182 | uncertain significance | not provided | 2018-09-16 | no assertion criteria provided | research | |
Prevention |
RCV004751679 | SCV005350352 | uncertain significance | SALL1-related disorder | 2024-03-30 | no assertion criteria provided | clinical testing | The SALL1 c.466_477dup12 variant is predicted to result in an in-frame duplication (p.Ser156_Ser159dup). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |